Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4841 | 1304-85-4 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
antacid containing bismuth, sodium & magnesium carbonates, rutin, Khellin & Rhamnus bark powder; do not confuse with colloidal bismuth subcitrate
|
None
None
None
None
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Myasthenia gravis | 184.11 | 145.12 | 65 | 3768 | 16072 | 42601430 |
| Hyperphosphataemia | 150.65 | 145.12 | 53 | 3780 | 12951 | 42604551 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Myasthenia gravis | 225.10 | 107.46 | 65 | 3864 | 21446 | 110563924 |
| Hyperphosphataemia | 187.05 | 107.46 | 53 | 3876 | 16328 | 110569042 |
| Analgesic therapy | 157.05 | 107.46 | 39 | 3890 | 7245 | 110578125 |
| Activated partial thromboplastin time prolonged | 154.05 | 107.46 | 49 | 3880 | 22319 | 110563051 |
| Appendicolith | 153.19 | 107.46 | 44 | 3885 | 14211 | 110571159 |
| Drug therapy | 152.00 | 107.46 | 38 | 3891 | 7253 | 110578117 |
| Hypophosphataemia | 150.23 | 107.46 | 53 | 3876 | 33129 | 110552241 |
| Congenital hiatus hernia | 147.52 | 107.46 | 36 | 3893 | 6223 | 110579147 |
| Sleep disorder therapy | 146.12 | 107.46 | 37 | 3892 | 7434 | 110577936 |
| Anticoagulant therapy | 142.61 | 107.46 | 34 | 3895 | 5327 | 110580043 |
| Antacid therapy | 141.85 | 107.46 | 34 | 3895 | 5450 | 110579920 |
| Neuralgia | 134.12 | 107.46 | 54 | 3875 | 48424 | 110536946 |
| Blood phosphorus increased | 130.09 | 107.46 | 40 | 3889 | 16300 | 110569070 |
| Incorrect route of product administration | 129.24 | 107.46 | 57 | 3872 | 64004 | 110521366 |
| Appendicitis | 127.05 | 107.46 | 45 | 3884 | 28419 | 110556951 |
| Bacterial infection | 126.38 | 107.46 | 51 | 3878 | 45985 | 110539385 |
| End stage renal disease | 123.32 | 107.46 | 41 | 3888 | 21432 | 110563938 |
| Blood uric acid increased | 123.22 | 107.46 | 41 | 3888 | 21488 | 110563882 |
| Stress | 116.23 | 107.46 | 62 | 3867 | 105286 | 110480084 |
| Bronchopulmonary aspergillosis allergic | 113.26 | 107.46 | 31 | 3898 | 8395 | 110576975 |
| Ventricular fibrillation | 110.74 | 107.46 | 45 | 3884 | 41268 | 110544102 |
| Blood calcium increased | 109.82 | 107.46 | 36 | 3893 | 18004 | 110567366 |
| Gout | 109.00 | 107.46 | 43 | 3886 | 36523 | 110548847 |
None
| Source | Code | Description |
|---|---|---|
| ATC | A02BX12 | ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| MeSH PA | D000863 | Antacids |
| MeSH PA | D005765 | Gastrointestinal Agents |
| CHEBI has role | CHEBI:49201 | anti-ulcer drug |
None
None
None
None
None
None
None
| ID | Source |
|---|---|
| H19J064BA5 | UNII |
| D01642 | KEGG_DRUG |
| 4018999 | VUID |
| N0000147275 | NUI |
| 4018999 | VANDF |
| C0053791 | UMLSCUI |
| CHEBI:31293 | CHEBI |
| CHEMBL3833348 | ChEMBL_ID |
| 73415757 | PUBCHEM_CID |
| DB13209 | DRUGBANK_ID |
| C010804 | MESH_SUPPLEMENTAL_RECORD_UI |
| 19477 | RXNORM |
| 4289 | MMSL |
| 4882 | MMSL |
| d03594 | MMSL |
| 001913 | NDDF |
| 004332 | NDDF |
| 391852006 | SNOMEDCT_US |
| 421038002 | SNOMEDCT_US |
None